BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 9393978)

  • 1. Tumor suppressor protein p53 binds preferentially to supercoiled DNA.
    Palecek E; Vlk D; Stanková V; Brázda V; Vojtesek B; Hupp TR; Schaper A; Jovin TM
    Oncogene; 1997 Oct; 15(18):2201-9. PubMed ID: 9393978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of transition metals on binding of p53 protein to supercoiled DNA and to consensus sequence in DNA fragments.
    Palecek E; Brázdová M; Cernocká H; Vlk D; Brázda V; Vojtesek B
    Oncogene; 1999 Jun; 18(24):3617-25. PubMed ID: 10380883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific modulation of p53 binding to consensus sequence within supercoiled DNA by monoclonal antibodies.
    Brázda V; Paleĉek J; Pospísilová S; Vojtêsek B; Paleĉek E
    Biochem Biophys Res Commun; 2000 Jan; 267(3):934-9. PubMed ID: 10673394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of p53 sequence-specific binding by DNA supercoiling.
    Palecek E; Brázda V; Jagelská E; Pecinka P; Karlovská L; Brázdová M
    Oncogene; 2004 Mar; 23(12):2119-27. PubMed ID: 14755248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scanning force microscopy of the complexes of p53 core domain with supercoiled DNA.
    Jett SD; Cherny DI; Subramaniam V; Jovin TM
    J Mol Biol; 2000 Jun; 299(3):585-92. PubMed ID: 10835269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective binding of tumor suppressor p53 protein to topologically constrained DNA: Modulation by intercalative drugs.
    Pivonková H; Sebest P; Pecinka P; Tichá O; Nemcová K; Brázdová M; Jagelská EB; Brázda V; Fojta M
    Biochem Biophys Res Commun; 2010 Mar; 393(4):894-9. PubMed ID: 20175992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of p53 and its core domain to supercoiled DNA.
    Palecek E; Brázdová M; Brázda V; Palecek J; Billová S; Subramaniam V; Jovin TM
    Eur J Biochem; 2001 Feb; 268(3):573-81. PubMed ID: 11168396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential binding of tumor suppressor p53 to positively or negatively supercoiled DNA involves the C-terminal domain.
    Mazur SJ; Sakaguchi K; Appella E; Wang XW; Harris CC; Bohr VA
    J Mol Biol; 1999 Sep; 292(2):241-9. PubMed ID: 10493872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The central region of BRCA1 binds preferentially to supercoiled DNA.
    Brázda V; Jagelska EB; Liao JC; Arrowsmith CH
    J Biomol Struct Dyn; 2009 Aug; 27(1):97-104. PubMed ID: 19492866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential binding of IFI16 protein to cruciform structure and superhelical DNA.
    Brázda V; Coufal J; Liao JC; Arrowsmith CH
    Biochem Biophys Res Commun; 2012 Jun; 422(4):716-20. PubMed ID: 22618232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Oxidation Agents and Metal Ions on Binding of p53 to Supercoiled DNA.
    Fojta M; Brazdova M; Cernocka H; Pecinka P; Brazda V; Palecek J; Jagelska E; Vojtesek B; Pospisilova S; Subramaniam V; Jovin TM; Palecek E
    J Biomol Struct Dyn; 2000; 17 Suppl 1():177-83. PubMed ID: 22607421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity binding of tumor-suppressor protein p53 and HMGB1 to hemicatenated DNA loops.
    Stros M; Muselíková-Polanská E; Pospísilová S; Strauss F
    Biochemistry; 2004 Jun; 43(22):7215-25. PubMed ID: 15170359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA topology influences p53 sequence-specific DNA binding through structural transitions within the target sites.
    Jagelská EB; Brázda V; Pecinka P; Palecek E; Fojta M
    Biochem J; 2008 May; 412(1):57-63. PubMed ID: 18271758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electron and scanning force microscopy studies of alterations in supercoiled DNA tertiary structure.
    Cherny DI; Jovin TM
    J Mol Biol; 2001 Oct; 313(2):295-307. PubMed ID: 11800558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations of the supercoil-selective DNA binding of wild type p53 suggest a novel mechanism for controlling p53 function.
    Fojta M; Pivonkova H; Brazdova M; Nemcova K; Palecek J; Vojtesek B
    Eur J Biochem; 2004 Oct; 271(19):3865-76. PubMed ID: 15373832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tumor suppressor p53 domains in selective binding to supercoiled DNA.
    Brázdová M; Palecek J; Cherny DI; Billová S; Fojta M; Pecinka P; Vojtesek B; Jovin TM; Palecek E
    Nucleic Acids Res; 2002 Nov; 30(22):4966-74. PubMed ID: 12434001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequestering of p53 into DNA-protein filaments revealed by electron microscopy.
    Cherny DI; Brázdova M; Palecek J; Palecek E; Jovin TM
    Biophys Chem; 2005 Apr; 114(2-3):261-71. PubMed ID: 15829361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Searching for target sequences by p53 protein is influenced by DNA length.
    Brázda V; Jagelská EB; Fojta M; Palecek E
    Biochem Biophys Res Commun; 2006 Mar; 341(2):470-7. PubMed ID: 16426567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA bending due to specific p53 and p53 core domain-DNA interactions visualized by electron microscopy.
    Cherny DI; Striker G; Subramaniam V; Jett SD; Palecek E; Jovin TM
    J Mol Biol; 1999 Dec; 294(4):1015-26. PubMed ID: 10588903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of p53 protein redox states on binding to supercoiled and linear DNA.
    Fojta M; Kubicárová T; Vojtĕsek B; Palecek E
    J Biol Chem; 1999 Sep; 274(36):25749-55. PubMed ID: 10464313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.